AzTrials
AzTrials

EsotropiaNCT01166503

Early Versus Delayed Surgery for Infantile Esotropia

An observational study of Esotropia, run by The Hospital for Sick Children at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this study is to determine whether corrective surgery done earlier than the current standard can better improve the visual and eye movement deficits in children with infantile esotropia (crossed eyes in infancy). Read more about this study

Who is it for?
Ages 3 to 23 months
Conditions the study is for
Esotropia
What is being tested?
mVEP Testing, Stereoacuity Testing and Optokinetic nystagmus testing
Type of treatment
Surgery or procedure
How many people
71 participants
Where
1 siteCanada
Study dates
May 2004to 26 Apr 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 23 months
  • All sexes
  • No healthy volunteers
  • Child

Study population: Patients with infantile esotropia will be enrolled from The Hospital for Sick Children in Toronto. Infants with characteristics that indicate low likelihood of spontaneous resolution will be studied.

Who may be able to join

  • onset of esotropia after 10 weeks of age;
  • constant esotropia ≥ 20° (40 prism diopter or PD) at near (1/3 m) on two examinations, separated by 2-4 weeks; and
  • refractive error ≤ +3.00 diopters (far-sightedness).

Who cannot join

  • gestational age < 34 weeks;
  • birth weight ≤ 1500 g;
  • ventilator treatment in the newborn period;
  • history of meningitis or other major medical event;
  • developmental delay;
  • incomitant or paralytic strabismus;
Show all 10Show fewer
  • manifest nystagmus or head bobbing;
  • prior eye muscle surgery;
  • prior treatment of amblyopia or spectacle correction for refractive errors;
  • presence of structural ocular anomalies.

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • The Hospital for Sick Children

    Toronto, Ontario, M5G 1X8

Other trials in Canada

About this study

Official title: Early Versus Delayed Surgery for Infantile Esotropia: A Clinical Evaluation of Sensory and Motor Outcomes

The goal of this study is to determine whether corrective surgery done earlier than the current standard can better improve the visual and eye movement deficits in children with infantile esotropia (crossed eyes in infancy).

Read the detailed description

While there is a uniform agreement among pediatric ophthalmologists that most infantile esotropia requires surgical correction, the proper timing of surgery is controversial. In North America, the typical age at surgery ranges from 11-18 months. Unfortunately, despite successful surgical realignment of the eyes, the sensory and eye movement deficits often persist. Recently, some pediatric ophthalmologists have advocated earlier surgery. The rationale for early surgery stems from animal and human research showing that early realignment of the eyes within an early critical period allows normal development of the sensory and eye movement systems.

Conditions
Esotropia
Being tested
mVEP Testing, Stereoacuity Testing, Optokinetic nystagmus testing, Motion detection testing, Motion discrimination testing
Keywords
pediatrics, Esotropia, Surgery
Medical subject headings
Esotropia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • mVEP TestingProcedure or surgery

    Five small sensors are placed on the head which record the brain's response to moving stripes that are displayed on a computer screen. Each eye is tested while the other eye is patched. Each recording trial lasts about 10 seconds, and several trials are done for each eye.

  • Stereoacuity TestingProcedure or surgery

    Subjects will have their 3D perception measured using standard clinical stereo tests (Randot, Lang, Titmus).

  • Optokinetic nystagmus testingProcedure or surgery

    Subjects will be asked to view a screen with vertical stripes moving in both leftward and rightward directions while their eye movements are recorded using a remote video-based eye tracker.

  • Motion detection testingProcedure or surgery

    Subjects will view a computer screen that has two panels of dots on them. The subject will be required to pick which panel has a section of dots that are moving in a specific direction (ie. nasalward/temporalward).

  • Motion discrimination testingProcedure or surgery

    Subjects will view a computer screen that has two panels of randomly moving dots on them. The subject will be required to pick which panel has a section of dots that are moving in a specific direction (ie. nasalward/temporalward).

Study groups in NCT01166503
Study groupRoleWhat they receive
Early SurgeryThis group will be made up of subjects whose parents choose to have them undergo corrective surgery at or before age 11 months.
Receives: Procedure: mVEP Testing; Procedure: Stereoacuity Testing; Procedure: Optokinetic nystagmus testing; Procedure: Motion detection testing; Procedure: Motion discrimination testing
Standard SurgeryThis group will be made up of subjects who present after age 11 months or whose parents choose to have them undergo corrective surgery between 11-18 months.
Receives: Procedure: mVEP Testing; Procedure: Stereoacuity Testing; Procedure: Optokinetic nystagmus testing; Procedure: Motion detection testing; Procedure: Motion discrimination testing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Motion visual evoked potential (mVEPs) asymmetry

    mVEP measures the perception of nasalward and temporalward motion for each eye at the cortical level. A nasal bias index (NBI) is calculated, which will show whether subjects perceive motion better for one direction over the other.

    Measured: at age 2 years

  2. Stereopsis

    This measures the level of 3D depth perception.

    Measured: at 2 and 5 years of age

  3. Optokinetic nystagmus (OKN) asymmetry

    OKN is measured in both the nasalward and temporalward directions for each eye. From this a nasal bias index (NBI) is calculated, which will show whether subjects perceive motion better in one direction or the other.

    Measured: at age 5 years

  4. Global Motion Perception

    Motion perception will be tested using two tasks: motion detection (at age 2 and 5 years) and motion discrimination (at age 5 years).

    Measured: at 2 and 5 years of age

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jul 2010 (estimated)
  2. Study startMay 2004
  3. Primary completion2 Apr 2018
  4. Study completion26 Apr 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
71 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01166503
Sponsor's protocol ID
1000005134
Status last verified
Jun 2018
First submitted
19 Jul 2010
Last updated
12 Jun 2018
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Esotropia, run by The Hospital for Sick Children at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Jun 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Motion visual evoked potential (mVEPs) asymmetry (time frame: at age 2 years). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jun 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in